Meet us at ASCO 2025
Clinakos Inc. is heading to ASCO25! We are thrilled to announce that Clinakos will be exhibiting at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 30–June 3. Come meet us at Booth 23155, where we display how we are transforming oncology research, commercialization, and patient outcomes with our Integrated […]
The Impact of Delayed Diagnosis in Rare Disease
The latest Delayed Diagnosis Study from the EveryLife Foundation reveals a staggering truth: delayed diagnosis of rare diseases can cost families and the healthcare system up to $517,000 per patient in avoidable expenses, with the average diagnostic journey stretching over six years and involving as many as 17 clinical encounters. This isn’t just a financial […]
World Hemophilia Day
As we celebrate World Hemophilia Day this April 17th, we would like to spotlight Shellye Horowitz’s inspiring story. Diagnosed with hemophilia at just 10 years old, she has faced significant challenges, from joint bleeds to complications due to delayed treatment. Despite these obstacles, Shellye empowered herself by learning to self-infuse clotting factors and has become […]
Meet us at ISPOR 2025
We are thrilled to announce that Clinakos Inc. will be attending ISPOR 2025, the premier global conference for Health Economics and Outcomes Research (HEOR), taking place from May 13-16, 2025, in Montreal, Quebec, Canada. From ground-breaking research to transformative ideas, this must-attend event brings together global healthcare leaders, researchers, and innovators to explore the latest […]
Clinakos is live at booth #54 at Reuters Pharma USA 2025
WE ARE LIVE NOW! We’ve landed at Booth #54 at Reuters Events Pharma USA 2025 in Philadelphia! Join us to meet our team and experience the future of life sciences with Clinakos Inc. Discover how we’re redefining healthcare through innovation. We’re excited to showcase how Clinakos Inc. is transforming the industry with Integrated Patient Data™ […]
Multiple Myeloma Awareness Month
As we mark Multiple Myeloma Awareness Month, we’re excited to highlight the groundbreaking advancements in therapies transforming patient care in the U.S. Recent breakthroughs include monoclonal antibodies, which have significantly improved outcomes when combined with standard therapies. CAR T-cell therapies offer personalized treatment options for relapsed or refractory cases, providing hope for patients who have […]
Clinakos will be exhibiting at Reuters Pharma USA 2025
We are thrilled to announce that Clinakos Inc. will be exhibiting at Reuters Events Pharma USA 2025! This is a unique opportunity to learn about how Clinakos is transforming the life sciences sector with its pioneering Integrated Patient Data™ and Medically Smart AI™. Our cutting-edge solutions are revolutionizing how life science companies engage with niche […]
Meet us at MAPS 2025
We’re excited to announce our participation in the upcoming MAPS Annual Conference, taking place from March 23 – 26, 2025, in New Orleans. This event presents an excellent opportunity to connect with clients, partners, and collaborators. We look forward to engaging in insightful discussions on groundbreaking solutions powered by Clinakos Inc. Integrated Patient Data™ and […]
February 28 is Rare Disease Day
Rare diseases disproportionately affect children, with a staggering two-thirds of American rare disease patients being kids. This sobering statistic underscores the critical importance of early detection and intervention – a mission that drives us at Clinakos Inc. Meet Anthony, whose story, shared by National Organization for Rare Disorders, puts a face to this urgent need. […]
Rare Disease Month February
As Rare Disease Month approaches this February, we turn our attention to the extraordinary stories of individuals navigating life with conditions that often defy quick diagnosis and straightforward treatment. Their journeys are a testament to resilience and the urgent need for innovation. Recently, I came across with the story of Faye Louise, a 40-year-old from […]
